The CCR5-Antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-Agonist Bryostatin-1

  1. López-Huertas, M.R.
  2. Jiménez-Tormo, L.
  3. Madrid-Elena, N.
  4. Gutiérrez, C.
  5. Rodríguez-Mora, S.
  6. Coiras, M.
  7. Alcamí, J.
  8. Moreno, S.
Journal:
Scientific Reports

ISSN: 2045-2322

Year of publication: 2017

Volume: 7

Issue: 1

Type: Article

DOI: 10.1038/S41598-017-02634-Y GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus